Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Headlines

Adaptimmune in ‘vein-to-vein’ deal with Cryoport’s SmartPak

Adaptimmune adopts Cryoport’s SmartPak logistic services for shipment of its oncology T-cell therapy candidates, under a three-year agreement.

N4 Pharma develops spiky-surfaced silica nanoparticle delivery system

N4 Pharma creates DNA and RNA transfection technology using silica nanoparticles with an irregular surface, which traps and protects nucleic acid during its journey to cells.

Nine ingredients to promote biosimilar uptake

Though the utilization of biosimilars in Europe is high, a report on the practices of eight countries suggests that more can be done to foster competition and remove barriers to entry.

Novo Nordisk looks to bluebird for gene therapy targets

Novo Nordisk partners with bluebird on a three-year research arrangement looking to discover gene therapy candidates for the treatment of genetic diseases, including hemophilia.

GSK adopts Lyell’s services to improve T cell ‘fitness’

GSK taps Lyell’s technology to delay ‘exhaustion’ of T cells and will explore creating a new platform to develop cell and gene therapies for rare cancers.